| Sarah Ann Janish, PT, DPT | |
|
695 Mitzi St, Muskegon, MI 49445-3232 | |
| (231) 744-1641 | |
| Not Available |
| Full Name | Sarah Ann Janish |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 695 Mitzi St, Muskegon, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053943464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 5501019491 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Ann Janish, PT, DPT 9715 Elms Rd, Birch Run, MI 48415-8482 Ph: (989) 482-1799 | Sarah Ann Janish, PT, DPT 695 Mitzi St, Muskegon, MI 49445-3232 Ph: (231) 744-1641 |
News Archive
Today, our departments released a report showing that the Obama Administration's historic efforts to go after criminals who steal from Medicare and Medicaid are paying off, especially in hotspots like Houston. The report shows that last year, we recovered a record $4.2 billion from those who prey on our health care system. In total, our efforts returned $14.9 billion over the last four years, more than double what was returned in the previous four years.
Researchers from the US tested the prophylactic potential of a combination of 2 mAbs administered 3 or 75 days before respiratory challenge in rhesus macaques. They used the rhesus macaque model to test the added benefit of combinatory parenteral administration of 2 high-affinity anti-SARS-CoV-2 mAbs - C144-LS and C135-LS. These mAbs were developed to neutralize the virus and tweaked to improve their pharmacokinetics.
Small cell lung cancer (SCLC) patients treated with high-dose chemotherapy did not have better survival rates than those treated with standard doses, according to a randomized controlled trial published online April 8 in the Journal of the National Cancer Institute .
3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).
› Verified 1 days ago
Mr. Jeffrey Allen Eaton, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2045 Holton Rd, Muskegon, MI 49445 Phone: 231-744-0077 Fax: 231-744-0030 | |
Dr. Houston Bedford, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1400 Mercy Dr Ste 100, Muskegon, MI 49444 Phone: 231-733-1326 | |
Miss Cibele Maziliauskas Granito, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1080 E Sternberg Rd, Muskegon, MI 49444 Phone: 231-799-2200 Fax: 231-799-2201 | |
Rachel Silver, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr Ste 100, Muskegon, MI 49444 Phone: 231-733-1326 Fax: 231-733-5212 | |
Ms. Tracy Lee, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 945 E Sherman Blvd, Muskegon, MI 49444 Phone: 616-935-3300 Fax: 616-935-3323 | |
Britta Poort, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 945 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-737-4374 Fax: 231-830-9196 |